thiazoles has been researched along with sns 314 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, DA; Baskaran, S; Bui, M; Elling, RA; Flanagan, WM; Fung, AD; Hanan, EJ; Harris, S; Heumann, SA; Hoch, U; Jacobs, JW; Lam, J; Lawrence, CE; Lew, W; McDowell, RS; Nannini, MA; O'Brien, T; Oslob, JD; Romanowski, MJ; Shen, W; Silverman, JA; Sopko, MM; Tangonan, BT; Teague, J; Yoburn, JC; Yu, CH; Zhong, M; Zimmerman, KM | 1 |
| Allen, DA; Baskaran, S; Bui, M; Delarosa, E; Fuchs-Knotts, T; Fung, AD; Hashash, A; Hau, J; Heumann, SA; Ivy, S; Jacobs, JW; Lew, W; Maung, J; McDowell, RS; Oslob, JD; Ritchie, S; Romanowski, MJ; Silverman, JA; Yang, W; Yu, CH; Zhong, M | 1 |
| Ballinger, MD; Flanagan, WM; Fucini, RV; Hogan, JN; Taverna, P; VanderPorten, EC | 1 |
| Arbitrario, JP; Belmont, BJ; Evanchik, MJ; Flanagan, WM; Fucini, RV; Hansen, SK; Harris, SO; Hashash, A; Hoch, U; Hogan, JN; Howlett, AR; Jacobs, JW; Lam, JW; Ritchie, SC; Romanowski, MJ; Silverman, JA; Stockett, DE; Taverna, P; Teague, JN; Zimmerman, KM | 1 |
| Klein, RQ; Lok, W; Saif, MW | 1 |
| Antonelli, A; Baldini, E; Catania, A; D'Andrea, V; D'Armiento, E; De Antoni, E; Gnessi, L; Guaitoli, E; Moretti, C; Morrone, S; Sorrenti, S; Ulisse, S | 1 |
| Armenia, E; Aurilio, C; Barbarisi, A; Barbarisi, M; Clemente, O; de Sena, G; Quagliariello, V; Rosso, F | 1 |
| Che, Z; Chen, P; Dong, W; Guo, X; Hou, D; Liu, F; Liu, H; Pan, Y; Wang, G; Wang, X; Wang, Z; Yang, D; Zhang, Q; Zhang, W | 1 |
1 review(s) available for thiazoles and sns 314
| Article | Year |
|---|---|
Aurora kinase inhibitors as anti-cancer therapy.
Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Benzamides; Benzimidazoles; Cyclohexanecarboxylic Acids; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Neoplasms; Organophosphates; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Quinazolines; Thiazoles; Urea | 2010 |
7 other study(ies) available for thiazoles and sns 314
| Article | Year |
|---|---|
Discovery of a potent and selective aurora kinase inhibitor.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Structure-Activity Relationship; Thiazoles | 2008 |
Water-soluble prodrugs of an Aurora kinase inhibitor.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Male; Mice; Phenylurea Compounds; Prodrugs; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Solubility; Thiazoles; Water | 2009 |
The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Mice; Microtubules; Phenylurea Compounds; Protein Serine-Threonine Kinases; Spindle Apparatus; Thiazoles; Xenograft Model Antitumor Assays | 2009 |
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Caspase 3; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; HCT116 Cells; HeLa Cells; Histones; HT29 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Structure; Neoplasms; Phenylurea Compounds; Phosphorylation; Protein Serine-Threonine Kinases; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Effects of the Aurora kinases pan-inhibitor SNS-314 mesylate on anaplastic thyroid cancer derived cell lines.
Topics: Apoptosis; Cell Cycle; Cell Proliferation; Humans; Mesylates; Phenylurea Compounds; Thiazoles; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured | 2012 |
New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Aurora Kinase A; Aurora Kinase B; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Cytokines; Dose-Response Relationship, Drug; Drug Carriers; Drug Synergism; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrogels; Inhibitory Concentration 50; Phenylurea Compounds; Protein Kinase Inhibitors; Quercetin; Thiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Time Factors | 2016 |
Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.
Topics: Adult; Aged; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Middle Aged; Models, Biological; Molecular Targeted Therapy; Nuclear Proteins; Phenylurea Compounds; Polyploidy; Prognosis; Protein Kinase Inhibitors; Thiazoles; Transcription Factors; Tumor Burden | 2017 |